Clinical Trial Update: Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treatment for newly diagnosed high-risk pediatric acute lymphoblastic leukemia; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Jae Wook Lee | Conditions: Pediatric Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING